瑞典全国研究:糖尿病患者二代药物洗脱支架失败风险显著升高
基于SWEDEHEART全国登记,纳入2010–2020年瑞典所有接受二代药物洗脱支架(DES)的患者160,523例,分为1型糖尿病、2型糖尿病和无糖尿病组。平均随访4.5年发生5,510例支架失败,完全校正后1型糖尿病支架失败风险HR 2.28(95%CI 1.97-2.65),2型糖尿病HR 1.35(95%CI 1.27-1.44),风险升高由支架内再狭窄和支架血栓共同贡献。
要点
- 1型糖尿病患者二代DES支架失败风险约为无糖尿病者的2.28倍。
- 2型糖尿病患者支架失败风险亦升高,HR 1.35(95%CI 1.27-1.44)。
- 风险升高由支架内再狭窄与支架血栓共同驱动。
核心结论
- 与无糖尿病者相比,1型糖尿病患者二代DES支架失败风险最高,2型糖尿病次之,风险升高由支架内再狭窄和支架血栓共同贡献。
研究设计与样本
- 瑞典全国观察性研究,纳入2010–2020年所有接受二代药物洗脱支架(DES)的患者,分为1型糖尿病、2型糖尿病和无糖尿病(参照)三组。
- 采用Cox回归模型估计校正后风险比(HR)及95%CI,并进行缺失协变量和以死亡为竞争风险的敏感性分析。
主要发现
- 平均随访4.5年期间共发生5,510例支架失败事件。
- 完全校正后支架失败HR:1型糖尿病2.28(95%CI 1.97-2.65),2型糖尿病1.35(95%CI 1.27-1.44),参照为无糖尿病者。
- 敏感性分析证实结果稳健,支架内再狭窄和支架血栓均对风险升高有贡献。
临床怎么用
- 对接受二代DES的糖尿病患者应认识其支架失败风险升高,1型糖尿病尤为突出,需加强术后随访与危险因素管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The association between diabetes and coronary stent failure is poorly established with second-generation drug-eluting stents (DES). We aimed to evaluate the risk of stent failure in patients with diabetes compared with those without diabetes after implantation of second-generation DES. RESEARCH DESIGN AND METHODS: All patients in Sweden who received second-generation DES between 2010 and 2020 were included and categorized into three groups: type 1 diabetes, type 2 diabetes, and without diabetes (reference group). The primary end point was stent failure, defined as in-stent restenosis or stent thrombosis. Adjusted hazard ratios (HRs) with 95% CIs were estimated by Cox regression models. Sensitivity analyses were performed to address missing data in covariates and account for death as a competing risk. RESULTS: The study included 160,523 patients: 2,406 with type 1 diabetes, 43,377 with type 2 diabetes, and 114,740 without diabetes. Seventy-one percent were male. Over a mean follow-up of 4.5 years, 5,510 stent failure events occurred. The fully adjusted HR for stent failure was 2.28 (95% CI 1.97-2.65) for patients with type 1 and 1.35 (95% CI 1.27-1.44) for patients with type 2 diabetes, compared with individuals without diabetes. Sensitivity analyses confirmed the robustness of the findings, with both in-stent restenosis and stent thrombosis contributing to the increased risk. CONCLUSIONS: We observed a significantly higher risk of second-generation DES stent failure in individuals with type 1 diabetes followed by those with type 2 diabetes, compared with individuals without diabetes. This elevated risk was attributed to both in-stent restenosis and stent thrombosis.
引用
- Santos-Pardo I, Andersson Franko M, Hofmann R, et al. Coronary Stent Failure in Patients With Diabetes: A Nationwide Observational Study From SWEDEHEART. Diabetes Care. 2026. PMID: 41299809. doi:10.2337/dc25-1624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。